LIXT
Lixte Biotechnology Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.21
−6.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-91.6%
Return on equity
-66.9%
Return on assets
-71.0%
Return on invested capital
0.00x
Asset turnover
-$4.3M
Cash from operations
$0.26
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026